The dysregulated activation of the β-catenin pathway results in the nuclear accumulation of β-catenin and the transcription of other oncogenes, including c-Myc and Cyclin D-1, which play a role in the initiation and advancement of cancer cell progression [59]. This evidence concerns the gene MYC and cancer.